NZ225188A - Somatostatin derivatives and pharmaceutical compositions - Google Patents

Somatostatin derivatives and pharmaceutical compositions

Info

Publication number
NZ225188A
NZ225188A NZ225188A NZ22518888A NZ225188A NZ 225188 A NZ225188 A NZ 225188A NZ 225188 A NZ225188 A NZ 225188A NZ 22518888 A NZ22518888 A NZ 22518888A NZ 225188 A NZ225188 A NZ 225188A
Authority
NZ
New Zealand
Prior art keywords
hydrogen
residue
formula
lys
alkyl
Prior art date
Application number
NZ225188A
Other languages
English (en)
Inventor
Rainer Albert
Wilfried Bauer
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ225188A publication Critical patent/NZ225188A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ225188A 1987-06-29 1988-06-27 Somatostatin derivatives and pharmaceutical compositions NZ225188A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
NZ225188A true NZ225188A (en) 1991-04-26

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ225188A NZ225188A (en) 1987-06-29 1988-06-27 Somatostatin derivatives and pharmaceutical compositions

Country Status (15)

Country Link
JP (1) JPS6426599A (hr)
KR (1) KR890000520A (hr)
AU (1) AU1840988A (hr)
BE (1) BE1002663A4 (hr)
CH (1) CH679045A5 (hr)
DK (1) DK353788A (hr)
ES (1) ES2010283A6 (hr)
FR (1) FR2617171B1 (hr)
GB (1) GB2206352B (hr)
IL (1) IL86876A0 (hr)
IT (1) IT1221065B (hr)
LU (1) LU87262A1 (hr)
NL (1) NL8801640A (hr)
NZ (1) NZ225188A (hr)
SE (1) SE8802413L (hr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
ATE291587T1 (de) * 2000-07-31 2005-04-15 Dabur Res Foundation Somatostatin analoge und deren verwendung zur behandlung von krebs
RU2263678C2 (ru) 2001-03-08 2005-11-10 Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд Антагонисты соматостатина
KR20030088494A (ko) * 2001-04-09 2003-11-19 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 소마토스타틴 작용제
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
IT8848133A0 (it) 1988-06-28
JPS6426599A (en) 1989-01-27
CH679045A5 (hr) 1991-12-13
DK353788A (da) 1988-12-30
GB8815257D0 (en) 1988-08-03
SE8802413D0 (sv) 1988-06-28
LU87262A1 (fr) 1989-03-08
SE8802413L (sv) 1988-12-30
KR890000520A (ko) 1989-03-15
AU1840988A (en) 1989-01-05
FR2617171A1 (fr) 1988-12-30
BE1002663A4 (fr) 1991-04-30
GB2206352A (en) 1989-01-05
DK353788D0 (da) 1988-06-27
GB2206352B (en) 1990-10-31
NL8801640A (nl) 1989-01-16
IL86876A0 (en) 1988-11-30
IT1221065B (it) 1990-06-21
FR2617171B1 (fr) 1994-10-14
ES2010283A6 (es) 1989-11-01

Similar Documents

Publication Publication Date Title
JP2744910B2 (ja) ペプチド誘導体類
NZ225188A (en) Somatostatin derivatives and pharmaceutical compositions
AU765076B2 (en) Covalently bridged insulin dimers
AU711423B2 (en) Cyclic peptide analogs of somatostatin
US5847066A (en) Analogs of growth hormone-releasing factor
EP2752425A1 (en) Glycosylated polypeptide and drug composition containing said polypeptide
IE66113B1 (en) Linear somatostatin analogues
DK167361B1 (da) Grf-analoge peptider, farmaceutisk acceptable salte heraf og fremgangsmaader til fremstilling af disse
US4490364A (en) CCK Agonists II
HU211603A9 (en) Nonapeptide bombesin antagonists
US4496543A (en) Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
EP0956296B1 (en) Somatostatin antagonists
US4405607A (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
EP0606463B1 (en) Neuromedin b receptor antagonists
EP0737691A1 (en) Bombesin analogs
DE3790635B4 (de) Verfahren zur Herstellung eines Peptidalkohols und Ausgangsverbindungen dafür
AU739557B2 (en) Cyclic peptide analogs of somatostatin
GB2224280A (en) Modified somatostatin
GB2233652A (en) Synthesis of peptide alcohols
GB2227488A (en) Modified somatostatin
PL157648B1 (en) The method of peptide derivative manufacture
DE3820770A1 (de) Polypeptide
FR2619566A1 (fr) Procede de preparation d'un peptide-alcool
CS228546B2 (cs) Způsob výroby pentapeptidů